# A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy

> **NCT06423703** · PHASE3 · COMPLETED · sponsor: **Tris Pharma, Inc.** · enrollment: 240 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Cebranopadol
- **DRUG:** Oxycodone IR
- **DRUG:** Placebo Only
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06423703
- **Lead sponsor:** Tris Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-18
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06423703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06423703, "A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06423703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*